25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

H Lundbeck A/S
Buy, Hold or Sell?

Let's analyze Lundbeck together

I guess you are interested in H Lundbeck A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of H Lundbeck A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about H Lundbeck A/S

I send you an email if I find something interesting about H Lundbeck A/S.

1. Quick Overview

1.1. Quick analysis of Lundbeck (30 sec.)










1.2. What can you expect buying and holding a share of Lundbeck? (30 sec.)

How much money do you get?

How much money do you get?
kr0.10
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
kr23.41
Expected worth in 1 year
kr25.25
How sure are you?
77.5%

+ What do you gain per year?

Total Gains per Share
kr2.54
Return On Investment
6.9%

For what price can you sell your share?

Current Price per Share
kr36.50
Expected price per share
kr34.00 - kr37.90
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Lundbeck (5 min.)




Live pricePrice per Share (EOD)
kr36.50
Intrinsic Value Per Share
kr50.65 - kr155.36
Total Value Per Share
kr74.06 - kr178.77

2.2. Growth of Lundbeck (5 min.)




Is Lundbeck growing?

Current yearPrevious yearGrowGrow %
How rich?$3.2b$2.9b$201m6.4%

How much money is Lundbeck making?

Current yearPrevious yearGrowGrow %
Making money$90.3m$86.5m$3.7m4.1%
Net Profit Margin12.4%12.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Lundbeck (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Lundbeck?

Welcome investor! Lundbeck's management wants to use your money to grow the business. In return you get a share of Lundbeck.

First you should know what it really means to hold a share of Lundbeck. And how you can make/lose money.

Speculation

The Price per Share of Lundbeck is kr36.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lundbeck.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lundbeck, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr23.41. Based on the TTM, the Book Value Change Per Share is kr0.46 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.46 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.17 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lundbeck.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.110.3%0.090.2%0.080.2%0.170.5%0.140.4%
Usd Book Value Change Per Share0.110.3%0.060.2%0.060.2%-0.31-0.9%-0.15-0.4%
Usd Dividend Per Share0.000.0%0.020.1%0.020.1%0.070.2%0.110.3%
Usd Total Gains Per Share0.110.3%0.090.2%0.080.2%-0.24-0.7%-0.04-0.1%
Usd Price Per Share4.67-4.33-3.70-1.84-0.92-
Price to Earnings Ratio10.76-20.80-12.98-7.59-3.80-
Price-to-Total Gains Ratio42.10--6.74--11.67--8.23--8.23-
Price to Book Ratio1.43-1.37-1.25-0.61-0.30-
Price-to-Total Gains Ratio42.10--6.74--11.67--8.23--8.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.09905
Number of shares196
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.07
Usd Book Value Change Per Share0.06-0.31
Usd Total Gains Per Share0.09-0.24
Gains per Quarter (196 shares)17.36-47.43
Gains per Year (196 shares)69.46-189.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
119505954-244-200
238101128108-488-390
357151197162-731-580
477201266216-975-770
596251335270-1219-960
6115302404325-1463-1150
7134352473379-1707-1340
8153402542433-1951-1530
9172453611487-2194-1720
10192503680541-2438-1910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%34.06.00.085.0%54.08.00.087.1%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%28.012.00.070.0%42.017.03.067.7%
Dividend per Share1.00.03.025.0%3.00.09.025.0%5.00.015.025.0%8.00.032.020.0%11.00.051.017.7%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%31.09.00.077.5%45.014.03.072.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of H Lundbeck A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7930.459+73%0.458+73%-2.226+381%-1.102+239%
Book Value Per Share--23.40922.671+3%21.175+11%47.549-51%52.543-55%
Current Ratio--1.8831.717+10%1.446+30%1.287+46%1.244+51%
Debt To Asset Ratio--0.4060.408-1%0.440-8%0.478-15%0.475-15%
Debt To Equity Ratio--0.6830.689-1%0.788-13%0.948-28%0.942-27%
Dividend Per Share---0.175-100%0.145-100%0.494-100%0.808-100%
Eps--0.7760.651+19%0.553+40%1.205-36%0.993-22%
Free Cash Flow Per Share--1.0751.040+3%0.885+21%1.674-36%2.137-50%
Free Cash Flow To Equity Per Share--1.0750.835+29%0.353+205%2.138-50%1.539-30%
Gross Profit Margin--1.0000.336+198%-2.341+334%42.497-98%15.531-94%
Intrinsic Value_10Y_max--155.361--------
Intrinsic Value_10Y_min--50.655--------
Intrinsic Value_1Y_max--9.577--------
Intrinsic Value_1Y_min--3.289--------
Intrinsic Value_3Y_max--33.340--------
Intrinsic Value_3Y_min--11.488--------
Intrinsic Value_5Y_max--62.610--------
Intrinsic Value_5Y_min--21.385--------
Market Cap7251893000.000-357%33133166398.00030794720563.815+8%26356545000.000+26%13120991512.763+153%6560495756.382+405%
Net Profit Margin--0.1410.124+14%0.127+11%0.106+33%0.064+122%
Operating Margin----0%0.087-100%0.041-100%0.035-100%
Operating Ratio--1.0100.994+2%0.824+22%0.881+15%0.913+11%
Pb Ratio1.559+8%1.4271.368+4%1.250+14%0.610+134%0.305+368%
Pe Ratio11.756+8%10.75820.801-48%12.977-17%7.593+42%3.796+183%
Price Per Share36.500+8%33.40031.025+8%26.491+26%13.206+153%6.603+406%
Price To Free Cash Flow Ratio8.492+8%7.7707.697+1%10.739-28%4.183+86%2.092+271%
Price To Total Gains Ratio46.008+8%42.101-6.738+116%-11.665+128%-8.231+120%-8.231+120%
Quick Ratio--0.5600.621-10%0.926-40%0.920-39%0.722-23%
Return On Assets--0.0200.017+16%0.016+19%0.014+40%0.011+80%
Return On Equity--0.0330.029+16%0.029+13%0.026+25%0.018+88%
Total Gains Per Share--0.7930.634+25%0.603+31%-1.732+318%-0.294+137%
Usd Book Value--3244113400.0003143494475.000+3%2942431250.000+10%2602324615.000+25%2099711955.000+55%
Usd Book Value Change Per Share--0.1110.064+73%0.064+73%-0.311+381%-0.154+239%
Usd Book Value Per Share--3.2703.167+3%2.958+11%6.643-51%7.340-55%
Usd Dividend Per Share---0.024-100%0.020-100%0.069-100%0.113-100%
Usd Eps--0.1080.091+19%0.077+40%0.168-36%0.139-22%
Usd Free Cash Flow--148920200.000144170400.000+3%123040775.000+21%102567740.000+45%87357902.500+70%
Usd Free Cash Flow Per Share--0.1500.145+3%0.124+21%0.234-36%0.299-50%
Usd Free Cash Flow To Equity Per Share--0.1500.117+29%0.049+205%0.299-50%0.215-30%
Usd Market Cap1013089452.100-357%4628703345.8014302022462.765+8%3682009336.500+26%1833002514.333+153%916501257.166+405%
Usd Price Per Share5.099+8%4.6664.334+8%3.701+26%1.845+153%0.922+406%
Usd Profit--107569000.00090316050.000+19%86579075.000+24%68886070.000+56%45290740.000+138%
Usd Revenue--761784100.000721934675.000+6%676881425.000+13%640824855.000+19%600685552.500+27%
Usd Total Gains Per Share--0.1110.089+25%0.084+31%-0.242+318%-0.041+137%
 EOD+2 -6MRQTTM+28 -7YOY+29 -75Y+18 -1810Y+18 -18

3.3 Fundamental Score

Let's check the fundamental score of H Lundbeck A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.756
Price to Book Ratio (EOD)Between0-11.559
Net Profit Margin (MRQ)Greater than00.141
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.560
Current Ratio (MRQ)Greater than11.883
Debt to Asset Ratio (MRQ)Less than10.406
Debt to Equity Ratio (MRQ)Less than10.683
Return on Equity (MRQ)Greater than0.150.033
Return on Assets (MRQ)Greater than0.050.020
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of H Lundbeck A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose37.200
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About H Lundbeck A/S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.

Fundamental data was last updated by Penke on 2024-11-13 05:35:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Lundbeck earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Lundbeck to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 14.1% means that kr0.14 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of H Lundbeck A/S:

  • The MRQ is 14.1%. The company is making a huge profit. +2
  • The TTM is 12.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.1%TTM12.4%+1.7%
TTM12.4%YOY12.7%-0.3%
TTM12.4%5Y10.6%+1.8%
5Y10.6%10Y6.4%+4.2%
4.3.1.2. Return on Assets

Shows how efficient Lundbeck is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lundbeck to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.0% Return on Assets means that Lundbeck generated kr0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of H Lundbeck A/S:

  • The MRQ is 2.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.0%TTM1.7%+0.3%
TTM1.7%YOY1.6%+0.0%
TTM1.7%5Y1.4%+0.3%
5Y1.4%10Y1.1%+0.3%
4.3.1.3. Return on Equity

Shows how efficient Lundbeck is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lundbeck to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.3% Return on Equity means Lundbeck generated kr0.03 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of H Lundbeck A/S:

  • The MRQ is 3.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.3%TTM2.9%+0.5%
TTM2.9%YOY2.9%-0.1%
TTM2.9%5Y2.6%+0.2%
5Y2.6%10Y1.8%+0.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of H Lundbeck A/S.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Lundbeck is operating .

  • Measures how much profit Lundbeck makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lundbeck to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of H Lundbeck A/S:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY8.7%-8.7%
TTM-5Y4.1%-4.1%
5Y4.1%10Y3.5%+0.6%
4.3.2.2. Operating Ratio

Measures how efficient Lundbeck is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.01 means that the operating costs are kr1.01 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of H Lundbeck A/S:

  • The MRQ is 1.010. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.994. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.010TTM0.994+0.016
TTM0.994YOY0.824+0.169
TTM0.9945Y0.881+0.113
5Y0.88110Y0.913-0.032
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of H Lundbeck A/S.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Lundbeck is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.88 means the company has kr1.88 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of H Lundbeck A/S:

  • The MRQ is 1.883. The company is able to pay all its short-term debts. +1
  • The TTM is 1.717. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.883TTM1.717+0.166
TTM1.717YOY1.446+0.271
TTM1.7175Y1.287+0.430
5Y1.28710Y1.244+0.043
4.4.3.2. Quick Ratio

Measures if Lundbeck is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lundbeck to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.56 means the company can pay off kr0.56 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of H Lundbeck A/S:

  • The MRQ is 0.560. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.621. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.560TTM0.621-0.062
TTM0.621YOY0.926-0.305
TTM0.6215Y0.920-0.299
5Y0.92010Y0.722+0.198
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of H Lundbeck A/S.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Lundbeck assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lundbeck to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.41 means that Lundbeck assets are financed with 40.6% credit (debt) and the remaining percentage (100% - 40.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of H Lundbeck A/S:

  • The MRQ is 0.406. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.408. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.406TTM0.408-0.002
TTM0.408YOY0.440-0.032
TTM0.4085Y0.478-0.070
5Y0.47810Y0.475+0.002
4.5.4.2. Debt to Equity Ratio

Measures if Lundbeck is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lundbeck to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 68.3% means that company has kr0.68 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of H Lundbeck A/S:

  • The MRQ is 0.683. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.689. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.683TTM0.689-0.006
TTM0.689YOY0.788-0.099
TTM0.6895Y0.948-0.259
5Y0.94810Y0.942+0.006
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Lundbeck generates.

  • Above 15 is considered overpriced but always compare Lundbeck to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 10.76 means the investor is paying kr10.76 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of H Lundbeck A/S:

  • The EOD is 11.756. Based on the earnings, the company is underpriced. +1
  • The MRQ is 10.758. Based on the earnings, the company is underpriced. +1
  • The TTM is 20.801. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD11.756MRQ10.758+0.998
MRQ10.758TTM20.801-10.043
TTM20.801YOY12.977+7.823
TTM20.8015Y7.593+13.208
5Y7.59310Y3.796+3.796
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of H Lundbeck A/S:

  • The EOD is 8.492. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.770. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.697. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD8.492MRQ7.770+0.721
MRQ7.770TTM7.697+0.074
TTM7.697YOY10.739-3.042
TTM7.6975Y4.183+3.514
5Y4.18310Y2.092+2.092
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Lundbeck is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of H Lundbeck A/S:

  • The EOD is 1.559. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.427. Based on the equity, the company is underpriced. +1
  • The TTM is 1.368. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.559MRQ1.427+0.132
MRQ1.427TTM1.368+0.059
TTM1.368YOY1.250+0.118
TTM1.3685Y0.610+0.758
5Y0.61010Y0.305+0.305
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in DKK. All numbers in thousands.

Summary
Total Assets39,087,000
Total Liabilities15,865,000
Total Stockholder Equity23,222,000
 As reported
Total Liabilities 15,865,000
Total Stockholder Equity+ 23,222,000
Total Assets = 39,087,000

Assets

Total Assets39,087,000
Total Current Assets15,170,000
Long-term Assets23,917,000
Total Current Assets
Cash And Cash Equivalents 6,153,000
Net Receivables 4,507,000
Inventory 4,510,000
Total Current Assets  (as reported)15,170,000
Total Current Assets  (calculated)15,170,000
+/-0
Long-term Assets
Property Plant Equipment 2,950,000
Long-term Assets  (as reported)23,917,000
Long-term Assets  (calculated)2,950,000
+/- 20,967,000

Liabilities & Shareholders' Equity

Total Current Liabilities8,055,000
Long-term Liabilities7,810,000
Total Stockholder Equity23,222,000
Total Current Liabilities
Accounts payable 4,317,000
Total Current Liabilities  (as reported)8,055,000
Total Current Liabilities  (calculated)4,317,000
+/- 3,738,000
Long-term Liabilities
Long term Debt 3,718,000
Capital Lease Obligations Min Short Term Debt432,000
Long-term Liabilities  (as reported)7,810,000
Long-term Liabilities  (calculated)4,150,000
+/- 3,660,000
Total Stockholder Equity
Retained Earnings 20,937,000
Total Stockholder Equity (as reported)23,222,000
Total Stockholder Equity (calculated)20,937,000
+/- 2,285,000
Other
Capital Stock996,000
Common Stock Shares Outstanding 992,011
Net Invested Capital 26,940,000
Net Working Capital 7,115,000
Property Plant and Equipment Gross 2,950,000



6.2. Balance Sheets Structured

Currency in DKK. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
0
0
17,127,000
16,874,000
18,314,000
18,352,000
18,005,000
18,572,000
18,820,000
19,802,000
20,534,000
20,530,000
20,693,000
20,461,000
21,563,000
23,152,000
23,381,000
23,446,000
23,649,000
23,453,000
22,954,000
24,928,000
25,637,000
26,528,000
20,746,000
22,183,000
21,325,000
20,614,000
20,300,000
20,032,000
20,210,000
20,678,000
19,199,000
20,257,000
19,756,000
19,753,000
21,703,000
22,402,000
23,011,000
21,722,000
22,082,000
23,471,000
35,757,000
34,867,000
35,090,000
34,590,000
36,029,000
34,465,000
34,036,000
35,119,000
34,653,000
35,071,000
37,275,000
39,305,000
37,452,000
36,624,000
37,242,000
37,672,000
37,407,000
37,852,000
39,087,000
39,087,00037,852,00037,407,00037,672,00037,242,00036,624,00037,452,00039,305,00037,275,00035,071,00034,653,00035,119,00034,036,00034,465,00036,029,00034,590,00035,090,00034,867,00035,757,00023,471,00022,082,00021,722,00023,011,00022,402,00021,703,00019,753,00019,756,00020,257,00019,199,00020,678,00020,210,00020,032,00020,300,00020,614,00021,325,00022,183,00020,746,00026,528,00025,637,00024,928,00022,954,00023,453,00023,649,00023,446,00023,381,00023,152,00021,563,00020,461,00020,693,00020,530,00020,534,00019,802,00018,820,00018,572,00018,005,00018,352,00018,314,00016,874,00017,127,000000
   > Total Current Assets 
0
0
0
6,155,000
5,702,000
6,627,000
7,545,000
6,756,000
7,811,000
8,280,000
9,331,000
8,803,000
8,939,000
7,725,000
7,811,000
9,181,000
10,896,000
10,510,000
11,298,000
11,363,000
11,328,000
6,969,000
8,421,000
9,386,000
9,471,000
7,330,000
7,983,000
7,660,000
7,691,000
7,289,000
7,459,000
7,524,000
8,734,000
8,008,000
9,297,000
8,844,000
8,560,000
10,515,000
11,250,000
11,649,000
10,097,000
8,578,000
9,803,000
9,038,000
8,661,000
9,408,000
9,865,000
10,105,000
8,107,000
8,145,000
9,132,000
8,612,000
9,044,000
10,549,000
12,034,000
11,412,000
11,134,000
12,150,000
12,648,000
13,289,000
13,770,000
15,170,000
15,170,00013,770,00013,289,00012,648,00012,150,00011,134,00011,412,00012,034,00010,549,0009,044,0008,612,0009,132,0008,145,0008,107,00010,105,0009,865,0009,408,0008,661,0009,038,0009,803,0008,578,00010,097,00011,649,00011,250,00010,515,0008,560,0008,844,0009,297,0008,008,0008,734,0007,524,0007,459,0007,289,0007,691,0007,660,0007,983,0007,330,0009,471,0009,386,0008,421,0006,969,00011,328,00011,363,00011,298,00010,510,00010,896,0009,181,0007,811,0007,725,0008,939,0008,803,0009,331,0008,280,0007,811,0006,756,0007,545,0006,627,0005,702,0006,155,000000
       Cash And Cash Equivalents 
0
0
0
1,960,000
1,330,000
1,920,000
2,995,000
2,294,000
2,389,000
2,895,000
3,212,000
2,467,000
2,511,000
1,640,000
2,194,000
2,747,000
2,869,000
3,485,000
3,847,000
4,817,000
4,551,000
1,424,000
2,092,000
3,651,000
3,160,000
1,787,000
1,334,000
1,504,000
1,383,000
1,436,000
1,785,000
2,200,000
2,728,000
1,443,000
2,087,000
2,155,000
1,771,000
2,561,000
2,831,000
3,605,000
1,967,000
1,743,000
2,975,000
3,008,000
2,283,000
3,241,000
3,703,000
3,924,000
1,661,000
1,691,000
2,504,000
2,279,000
1,614,000
2,298,000
3,406,000
3,421,000
2,882,000
3,663,000
4,248,000
5,010,000
5,113,000
6,153,000
6,153,0005,113,0005,010,0004,248,0003,663,0002,882,0003,421,0003,406,0002,298,0001,614,0002,279,0002,504,0001,691,0001,661,0003,924,0003,703,0003,241,0002,283,0003,008,0002,975,0001,743,0001,967,0003,605,0002,831,0002,561,0001,771,0002,155,0002,087,0001,443,0002,728,0002,200,0001,785,0001,436,0001,383,0001,504,0001,334,0001,787,0003,160,0003,651,0002,092,0001,424,0004,551,0004,817,0003,847,0003,485,0002,869,0002,747,0002,194,0001,640,0002,511,0002,467,0003,212,0002,895,0002,389,0002,294,0002,995,0001,920,0001,330,0001,960,000000
       Short-term Investments 
0
0
0
59,000
53,000
56,000
52,000
54,000
653,000
655,000
1,473,000
1,476,000
1,473,000
1,054,000
1,055,000
1,055,000
1,055,000
1,041,000
1,041,000
1,042,000
1,042,000
18,000
18,000
18,000
18,000
18,000
17,000
17,000
17,000
17,000
17,000
17,000
17,000
518,000
1,020,000
1,522,000
1,521,000
2,027,000
2,525,000
3,030,000
3,047,000
1,538,000
1,537,000
4,000
4,000
0
0
0
23,215,000
22,744,000
22,789,000
0
0
0
0
0
0
0
0
0
0
0
0000000000022,789,00022,744,00023,215,0000004,0004,0001,537,0001,538,0003,047,0003,030,0002,525,0002,027,0001,521,0001,522,0001,020,000518,00017,00017,00017,00017,00017,00017,00017,00018,00018,00018,00018,00018,0001,042,0001,042,0001,041,0001,041,0001,055,0001,055,0001,055,0001,054,0001,473,0001,476,0001,473,000655,000653,00054,00052,00056,00053,00059,000000
       Net Receivables 
0
0
0
2,307,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,644,000
3,563,000
4,176,000
4,211,000
4,014,000
2,965,000
4,144,000
4,507,000
4,507,0004,144,0002,965,0004,014,0004,211,0004,176,0003,563,0004,644,000000000000000000000000000000000000000000000000000002,307,000000
       Other Current Assets 
0
0
0
348,000
2,962,000
2,944,000
2,953,000
2,917,000
3,328,000
3,469,000
3,463,000
3,226,000
3,359,000
3,492,000
3,268,000
3,649,000
5,094,000
4,373,000
4,173,000
3,611,000
3,896,000
3,778,000
3,922,000
3,726,000
3,952,000
3,627,000
3,895,000
3,922,000
4,032,000
3,839,000
3,994,000
3,779,000
3,859,000
4,240,000
4,657,000
3,791,000
3,878,000
3,956,000
4,041,000
3,261,000
3,249,000
3,533,000
3,574,000
3,822,000
4,025,000
3,734,000
3,957,000
4,018,000
3,864,000
3,858,000
3,872,000
3,558,000
3,912,000
4,542,000
4,644,000
4,018,000
0
0
0
0
0
0
0000004,018,0004,644,0004,542,0003,912,0003,558,0003,872,0003,858,0003,864,0004,018,0003,957,0003,734,0004,025,0003,822,0003,574,0003,533,0003,249,0003,261,0004,041,0003,956,0003,878,0003,791,0004,657,0004,240,0003,859,0003,779,0003,994,0003,839,0004,032,0003,922,0003,895,0003,627,0003,952,0003,726,0003,922,0003,778,0003,896,0003,611,0004,173,0004,373,0005,094,0003,649,0003,268,0003,492,0003,359,0003,226,0003,463,0003,469,0003,328,0002,917,0002,953,0002,944,0002,962,000348,000000
   > Long-term Assets 
0
0
0
10,972,000
11,172,000
11,687,000
10,807,000
11,249,000
10,761,000
10,540,000
10,471,000
11,731,000
11,591,000
12,968,000
12,650,000
12,382,000
12,256,000
12,871,000
12,148,000
12,286,000
12,125,000
15,985,000
16,507,000
16,251,000
17,057,000
13,416,000
14,200,000
13,665,000
12,923,000
13,011,000
12,573,000
12,686,000
11,944,000
11,191,000
10,960,000
10,912,000
11,193,000
11,188,000
11,152,000
11,362,000
11,625,000
13,504,000
13,668,000
26,719,000
26,206,000
25,682,000
24,725,000
25,924,000
26,358,000
25,891,000
25,987,000
26,041,000
26,027,000
26,726,000
27,271,000
26,040,000
25,490,000
25,092,000
25,024,000
24,118,000
24,082,000
23,917,000
23,917,00024,082,00024,118,00025,024,00025,092,00025,490,00026,040,00027,271,00026,726,00026,027,00026,041,00025,987,00025,891,00026,358,00025,924,00024,725,00025,682,00026,206,00026,719,00013,668,00013,504,00011,625,00011,362,00011,152,00011,188,00011,193,00010,912,00010,960,00011,191,00011,944,00012,686,00012,573,00013,011,00012,923,00013,665,00014,200,00013,416,00017,057,00016,251,00016,507,00015,985,00012,125,00012,286,00012,148,00012,871,00012,256,00012,382,00012,650,00012,968,00011,591,00011,731,00010,471,00010,540,00010,761,00011,249,00010,807,00011,687,00011,172,00010,972,000000
       Property Plant Equipment 
0
0
0
3,049,000
3,003,000
3,004,000
2,931,000
3,046,000
3,018,000
2,992,000
2,759,000
2,814,000
2,801,000
2,788,000
2,768,000
2,793,000
2,787,000
2,773,000
2,765,000
2,778,000
2,748,000
2,722,000
2,711,000
2,724,000
2,715,000
2,681,000
2,252,000
2,246,000
2,202,000
2,190,000
2,204,000
2,162,000
1,974,000
1,938,000
1,923,000
1,990,000
1,950,000
1,946,000
1,954,000
2,018,000
2,435,000
2,450,000
2,509,000
2,674,000
2,639,000
2,637,000
2,652,000
2,733,000
2,758,000
2,752,000
2,789,000
2,907,000
2,893,000
2,901,000
2,920,000
2,942,000
2,900,000
2,870,000
2,846,000
2,881,000
2,902,000
2,950,000
2,950,0002,902,0002,881,0002,846,0002,870,0002,900,0002,942,0002,920,0002,901,0002,893,0002,907,0002,789,0002,752,0002,758,0002,733,0002,652,0002,637,0002,639,0002,674,0002,509,0002,450,0002,435,0002,018,0001,954,0001,946,0001,950,0001,990,0001,923,0001,938,0001,974,0002,162,0002,204,0002,190,0002,202,0002,246,0002,252,0002,681,0002,715,0002,724,0002,711,0002,722,0002,748,0002,778,0002,765,0002,773,0002,787,0002,793,0002,768,0002,788,0002,801,0002,814,0002,759,0002,992,0003,018,0003,046,0002,931,0003,004,0003,003,0003,049,000000
       Goodwill 
0
0
0
3,520,000
0
0
0
3,792,000
0
0
0
0
0
0
0
3,818,000
0
0
0
3,680,000
0
0
0
4,076,000
0
0
0
4,475,000
0
0
0
4,599,000
0
0
0
4,124,000
0
0
0
4,300,000
0
0
0
5,278,000
0
0
0
4,845,000
0
0
0
5,377,000
0
0
0
5,667,000
0
0
0
5,507,000
0
0
005,507,0000005,667,0000005,377,0000004,845,0000005,278,0000004,300,0000004,124,0000004,599,0000004,475,0000004,076,0000003,680,0000003,818,00000000003,792,0000003,520,000000
       Intangible Assets 
0
0
0
4,204,000
7,977,000
8,423,000
7,621,000
4,220,000
7,506,000
7,287,000
7,407,000
8,445,000
8,269,000
9,556,000
0
5,210,000
0
0
0
5,397,000
0
0
0
8,594,000
0
0
0
5,319,000
0
0
0
4,240,000
0
0
0
3,441,000
0
0
0
3,723,000
0
0
0
18,121,000
0
0
0
17,893,000
0
0
0
17,373,000
0
0
0
16,833,000
0
0
0
15,185,000
0
0
0015,185,00000016,833,00000017,373,00000017,893,00000018,121,0000003,723,0000003,441,0000004,240,0000005,319,0000008,594,0000005,397,0000005,210,00009,556,0008,269,0008,445,0007,407,0007,287,0007,506,0004,220,0007,621,0008,423,0007,977,0004,204,000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
387,000
1,131,000
0
442,000
0
0
0
0
0000442,00001,131,000387,000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
8,324,000
6,897,000
7,755,000
7,585,000
6,883,000
7,532,000
7,097,000
7,465,000
7,758,000
7,917,000
7,786,000
7,357,000
8,365,000
9,181,000
9,990,000
9,940,000
10,168,000
10,192,000
9,548,000
10,968,000
12,111,000
12,218,000
10,561,000
13,188,000
12,540,000
11,881,000
11,438,000
10,873,000
10,516,000
10,857,000
8,504,000
8,712,000
7,575,000
8,120,000
9,144,000
8,866,000
8,760,000
9,003,000
8,584,000
9,104,000
21,203,000
20,793,000
20,598,000
19,915,000
19,056,000
17,242,000
16,496,000
17,036,000
16,374,000
16,625,000
17,679,000
18,386,000
16,673,000
15,644,000
15,670,000
15,367,000
15,362,000
15,417,000
15,865,000
15,865,00015,417,00015,362,00015,367,00015,670,00015,644,00016,673,00018,386,00017,679,00016,625,00016,374,00017,036,00016,496,00017,242,00019,056,00019,915,00020,598,00020,793,00021,203,0009,104,0008,584,0009,003,0008,760,0008,866,0009,144,0008,120,0007,575,0008,712,0008,504,00010,857,00010,516,00010,873,00011,438,00011,881,00012,540,00013,188,00010,561,00012,218,00012,111,00010,968,0009,548,00010,192,00010,168,0009,940,0009,990,0009,181,0008,365,0007,357,0007,786,0007,917,0007,758,0007,465,0007,097,0007,532,0006,883,0007,585,0007,755,0006,897,0008,324,000000
   > Total Current Liabilities 
0
0
0
4,537,000
3,872,000
4,769,000
4,650,000
4,035,000
4,657,000
4,170,000
4,600,000
4,696,000
4,733,000
4,575,000
3,983,000
4,981,000
5,797,000
6,648,000
6,274,000
6,518,000
6,473,000
5,794,000
7,139,000
7,202,000
7,303,000
6,377,000
7,812,000
7,748,000
7,474,000
7,243,000
7,586,000
7,776,000
8,135,000
6,643,000
6,856,000
6,479,000
6,995,000
8,052,000
7,873,000
7,576,000
7,626,000
6,783,000
7,226,000
10,280,000
7,865,000
8,062,000
8,104,000
10,012,000
7,964,000
8,438,000
9,084,000
8,818,000
7,830,000
8,503,000
9,136,000
8,199,000
7,446,000
7,690,000
8,038,000
7,990,000
7,869,000
8,055,000
8,055,0007,869,0007,990,0008,038,0007,690,0007,446,0008,199,0009,136,0008,503,0007,830,0008,818,0009,084,0008,438,0007,964,00010,012,0008,104,0008,062,0007,865,00010,280,0007,226,0006,783,0007,626,0007,576,0007,873,0008,052,0006,995,0006,479,0006,856,0006,643,0008,135,0007,776,0007,586,0007,243,0007,474,0007,748,0007,812,0006,377,0007,303,0007,202,0007,139,0005,794,0006,473,0006,518,0006,274,0006,648,0005,797,0004,981,0003,983,0004,575,0004,733,0004,696,0004,600,0004,170,0004,657,0004,035,0004,650,0004,769,0003,872,0004,537,000000
       Short-term Debt 
0
0
0
0
0
0
0
0
12,000
13,000
13,000
30,000
18,000
19,000
19,000
19,000
18,000
18,000
18,000
19,000
9,000
9,000
9,000
84,000
0
0
0
83,000
83,000
83,000
83,000
188,000
85,000
43,000
43,000
0
0
0
0
0
62,000
158,000
165,000
2,079,000
77,000
76,000
215,000
2,077,000
479,000
77,000
78,000
86,000
84,000
87,000
88,000
88,000
82,000
81,000
80,000
0
0
0
00080,00081,00082,00088,00088,00087,00084,00086,00078,00077,000479,0002,077,000215,00076,00077,0002,079,000165,000158,00062,0000000043,00043,00085,000188,00083,00083,00083,00083,00000084,0009,0009,0009,00019,00018,00018,00018,00019,00019,00019,00018,00030,00013,00013,00012,00000000000
       Accounts payable 
0
0
0
997,000
805,000
850,000
1,019,000
1,237,000
1,087,000
1,276,000
1,181,000
1,526,000
1,207,000
1,252,000
1,140,000
1,599,000
2,228,000
1,528,000
1,487,000
1,967,000
1,594,000
1,763,000
1,889,000
4,930,000
4,592,000
4,166,000
4,613,000
4,349,000
4,111,000
3,866,000
3,955,000
3,650,000
3,829,000
3,200,000
3,130,000
3,203,000
2,826,000
4,057,000
4,095,000
4,078,000
3,833,000
3,621,000
3,750,000
3,933,000
3,631,000
3,592,000
3,575,000
3,740,000
3,667,000
3,686,000
4,271,000
3,914,000
4,138,000
4,452,000
4,603,000
4,251,000
3,787,000
4,052,000
4,065,000
4,410,000
4,188,000
4,317,000
4,317,0004,188,0004,410,0004,065,0004,052,0003,787,0004,251,0004,603,0004,452,0004,138,0003,914,0004,271,0003,686,0003,667,0003,740,0003,575,0003,592,0003,631,0003,933,0003,750,0003,621,0003,833,0004,078,0004,095,0004,057,0002,826,0003,203,0003,130,0003,200,0003,829,0003,650,0003,955,0003,866,0004,111,0004,349,0004,613,0004,166,0004,592,0004,930,0001,889,0001,763,0001,594,0001,967,0001,487,0001,528,0002,228,0001,599,0001,140,0001,252,0001,207,0001,526,0001,181,0001,276,0001,087,0001,237,0001,019,000850,000805,000997,000000
       Other Current Liabilities 
0
0
0
3,540,000
3,067,000
3,919,000
3,631,000
2,798,000
3,558,000
2,881,000
3,406,000
3,004,000
3,508,000
3,304,000
2,824,000
3,313,000
3,551,000
5,102,000
4,769,000
4,474,000
4,870,000
4,022,000
5,241,000
2,139,000
2,711,000
2,211,000
3,199,000
3,245,000
3,280,000
3,294,000
3,548,000
3,781,000
4,221,000
3,400,000
3,683,000
3,276,000
4,169,000
3,995,000
3,778,000
3,498,000
3,731,000
3,004,000
3,311,000
96,000
4,157,000
4,394,000
4,314,000
3,520,000
2,984,000
3,982,000
4,154,000
4,818,000
3,608,000
3,964,000
4,445,000
3,860,000
3,577,000
3,557,000
3,893,000
0
0
0
0003,893,0003,557,0003,577,0003,860,0004,445,0003,964,0003,608,0004,818,0004,154,0003,982,0002,984,0003,520,0004,314,0004,394,0004,157,00096,0003,311,0003,004,0003,731,0003,498,0003,778,0003,995,0004,169,0003,276,0003,683,0003,400,0004,221,0003,781,0003,548,0003,294,0003,280,0003,245,0003,199,0002,211,0002,711,0002,139,0005,241,0004,022,0004,870,0004,474,0004,769,0005,102,0003,551,0003,313,0002,824,0003,304,0003,508,0003,004,0003,406,0002,881,0003,558,0002,798,0003,631,0003,919,0003,067,0003,540,000000
   > Long-term Liabilities 
0
0
0
3,787,000
3,025,000
2,986,000
2,935,000
2,848,000
2,875,000
2,927,000
2,865,000
3,062,000
3,184,000
3,211,000
3,374,000
3,384,000
3,384,000
3,342,000
3,666,000
3,650,000
3,719,000
3,754,000
3,829,000
4,909,000
4,915,000
4,184,000
5,376,000
4,792,000
4,407,000
4,195,000
3,287,000
2,740,000
2,722,000
1,861,000
1,856,000
1,096,000
1,125,000
1,092,000
993,000
1,184,000
1,377,000
1,801,000
1,878,000
10,923,000
12,928,000
12,536,000
11,811,000
9,044,000
9,278,000
8,058,000
7,952,000
7,556,000
8,795,000
9,176,000
9,250,000
8,474,000
8,198,000
7,980,000
7,329,000
7,372,000
7,548,000
7,810,000
7,810,0007,548,0007,372,0007,329,0007,980,0008,198,0008,474,0009,250,0009,176,0008,795,0007,556,0007,952,0008,058,0009,278,0009,044,00011,811,00012,536,00012,928,00010,923,0001,878,0001,801,0001,377,0001,184,000993,0001,092,0001,125,0001,096,0001,856,0001,861,0002,722,0002,740,0003,287,0004,195,0004,407,0004,792,0005,376,0004,184,0004,915,0004,909,0003,829,0003,754,0003,719,0003,650,0003,666,0003,342,0003,384,0003,384,0003,374,0003,211,0003,184,0003,062,0002,865,0002,927,0002,875,0002,848,0002,935,0002,986,0003,025,0003,787,000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,058,000
2,983,000
0
3,119,000
0
0
0
0
00003,119,00002,983,0003,058,000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
8,803,000
9,977,000
10,559,000
10,767,000
11,122,000
11,040,000
11,723,000
12,337,000
12,776,000
12,613,000
12,907,000
13,104,000
13,198,000
13,971,000
13,391,000
13,506,000
13,481,000
13,261,000
13,406,000
13,960,000
13,526,000
14,310,000
10,185,000
8,995,000
8,785,000
8,733,000
8,862,000
9,159,000
9,694,000
9,821,000
10,695,000
11,545,000
12,181,000
11,633,000
12,559,000
13,536,000
14,251,000
12,719,000
13,498,000
14,367,000
14,554,000
14,074,000
14,492,000
14,675,000
16,973,000
17,223,000
17,540,000
18,083,000
18,279,000
18,446,000
19,596,000
20,919,000
20,779,000
20,980,000
21,572,000
22,305,000
22,045,000
22,435,000
23,222,000
23,222,00022,435,00022,045,00022,305,00021,572,00020,980,00020,779,00020,919,00019,596,00018,446,00018,279,00018,083,00017,540,00017,223,00016,973,00014,675,00014,492,00014,074,00014,554,00014,367,00013,498,00012,719,00014,251,00013,536,00012,559,00011,633,00012,181,00011,545,00010,695,0009,821,0009,694,0009,159,0008,862,0008,733,0008,785,0008,995,00010,185,00014,310,00013,526,00013,960,00013,406,00013,261,00013,481,00013,506,00013,391,00013,971,00013,198,00013,104,00012,907,00012,613,00012,776,00012,337,00011,723,00011,040,00011,122,00010,767,00010,559,0009,977,0008,803,000000
   Common Stock
0
0
0
980,000
980,000
980,000
980,000
980,000
980,000
980,000
980,000
980,000
980,000
980,000
980,000
980,000
980,000
980,000
980,000
981,000
981,000
982,000
982,000
982,000
982,000
983,000
986,000
987,000
987,000
988,000
989,000
988,000
988,000
992,000
995,000
995,000
995,000
995,000
995,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
996,000
0
0
0
000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000996,000995,000995,000995,000995,000995,000992,000988,000988,000989,000988,000987,000987,000986,000983,000982,000982,000982,000982,000981,000981,000980,000980,000980,000980,000980,000980,000980,000980,000980,000980,000980,000980,000980,000980,000980,000980,000000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
-633,000
-230,000
437,000
-270,000
-57,000
-396,000
-486,000
-191,000
41,000
-87,000
178,000
82,000
18,000
118,000
31,000
-134,000
-194,000
-194,000
-150,000
385,000
646,000
1,518,000
1,278,000
1,318,000
1,502,000
1,274,000
1,287,000
1,260,000
934,000
977,000
1,099,000
988,000
1,016,000
849,000
757,000
673,000
748,000
715,000
695,000
805,000
807,000
981,000
838,000
542,000
229,000
331,000
308,000
520,000
712,000
901,000
1,541,000
2,169,000
1,594,000
1,526,000
1,507,000
1,556,000
0
0
0
0001,556,0001,507,0001,526,0001,594,0002,169,0001,541,000901,000712,000520,000308,000331,000229,000542,000838,000981,000807,000805,000695,000715,000748,000673,000757,000849,0001,016,000988,0001,099,000977,000934,0001,260,0001,287,0001,274,0001,502,0001,318,0001,278,0001,518,000646,000385,000-150,000-194,000-194,000-134,00031,000118,00018,00082,000178,000-87,00041,000-191,000-486,000-396,000-57,000-270,000437,000-230,000-633,000000



6.3. Balance Sheets

Currency in DKK. All numbers in thousands.




6.4. Cash Flows

Currency in DKK. All numbers in thousands.




6.5. Income Statements

Currency in DKK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in DKK. All numbers in thousands.

Gross Profit (+$)
totalRevenue19,912,000
Cost of Revenue-4,485,000
Gross Profit15,427,00015,427,000
 
Operating Income (+$)
Gross Profit15,427,000
Operating Expense-16,717,000
Operating Income3,195,000-1,290,000
 
Operating Expense (+$)
Research Development3,457,000
Selling General Administrative8,775,000
Selling And Marketing Expenses0
Operating Expense16,717,00012,232,000
 
Net Interest Income (+$)
Interest Income86,000
Interest Expense-54,000
Other Finance Cost-43,000
Net Interest Income-11,000
 
Pretax Income (+$)
Operating Income3,195,000
Net Interest Income-11,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,993,0003,195,000
EBIT - interestExpense = -54,000
2,290,000
2,344,000
Interest Expense54,000
Earnings Before Interest and Taxes (EBIT)03,047,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,993,000
Tax Provision-703,000
Net Income From Continuing Ops2,290,0002,290,000
Net Income2,290,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net011,000
 

Technical Analysis of Lundbeck
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lundbeck. The general trend of Lundbeck is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lundbeck's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of H Lundbeck A/S.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 37.30 < 37.65 < 37.90.

The bearish price targets are: 34.95 > 34.05 > 34.00.

Tweet this
H Lundbeck A/S Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of H Lundbeck A/S. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

H Lundbeck A/S Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of H Lundbeck A/S.

H Lundbeck A/S Daily Moving Average Convergence/Divergence (MACD) ChartH Lundbeck A/S Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of H Lundbeck A/S. The current adx is .

H Lundbeck A/S Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of H Lundbeck A/S.

H Lundbeck A/S Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of H Lundbeck A/S.

H Lundbeck A/S Daily Relative Strength Index (RSI) ChartH Lundbeck A/S Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of H Lundbeck A/S.

H Lundbeck A/S Daily Stochastic Oscillator ChartH Lundbeck A/S Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of H Lundbeck A/S.

H Lundbeck A/S Daily Commodity Channel Index (CCI) ChartH Lundbeck A/S Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of H Lundbeck A/S.

H Lundbeck A/S Daily Chande Momentum Oscillator (CMO) ChartH Lundbeck A/S Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of H Lundbeck A/S.

H Lundbeck A/S Daily Williams %R ChartH Lundbeck A/S Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of H Lundbeck A/S.

H Lundbeck A/S Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of H Lundbeck A/S.

H Lundbeck A/S Daily Average True Range (ATR) ChartH Lundbeck A/S Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of H Lundbeck A/S.

H Lundbeck A/S Daily On-Balance Volume (OBV) ChartH Lundbeck A/S Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of H Lundbeck A/S.

H Lundbeck A/S Daily Money Flow Index (MFI) ChartH Lundbeck A/S Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for H Lundbeck A/S.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

H Lundbeck A/S Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of H Lundbeck A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose37.200
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Lundbeck with someone you think should read this too:
  • Are you bullish or bearish on Lundbeck? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lundbeck? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about H Lundbeck A/S

I send you an email if I find something interesting about H Lundbeck A/S.


Comments

How you think about this?

Leave a comment

Stay informed about H Lundbeck A/S.

Receive notifications about H Lundbeck A/S in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.